Emerging Therapeutic Targets in Oncologic Photodynamic Therapy

Area of Science:

• Oncology
• Biochemistry
• Systems Medicine

Background:

• Reactive oxygen species (ROS) drive cancer progression and therapy sensitivity.
• Photodynamic therapy (PDT) uses singlet oxygen for cancer treatment with a favorable toxicological profile.
• Knowledge gaps in PDT's molecular mechanisms hinder clinical translation.

Purpose of the Study:

• Critically analyze recent advances in redox and inflammatory networks relevant to PDT.
• Identify emerging therapeutic targets and pharmaceutical tools for PDT.
• Investigate PDT's impact on cell death and therapy resistance.

Main Methods:

• Systems medicine approach to analyze cellular responses to PDT-induced singlet oxygen.
• Examination of molecular networks, cell death, and repair mechanisms.
• Focus on immunogenic cell death and boosting anti-tumor immunity.

Main Results:

• NRF2 (a transcription factor) identified as a key target for enhancing PDT efficacy.
• Analysis of cellular responses and molecular networks under PDT stress.
• Exploration of therapeutic strategies to boost anti-tumor immunity via immunogenic cell death.

Conclusions:

• In-depth molecular investigations correlating with clinical data are needed for PDT.
• A systems medicine approach is essential to understand PDT's complex biological signature.
• Further research will guide PDT translation to clinic and development of improved therapeutic strategies.